Enveric

We are now well into what is often called the “psychedelic renaissance,” and the field has made genuine progress alongside all the early excitement. Many groups new to the realities…

Psychedelic drugs have the potential to become an effective treatment for crippling mental health conditions such as depression. In this article, we take a look at six of the top…

Richard Zwicky spoke with Dr. Joseph Tucker, CEO of Enveric Biosciences about their development of non-hallucinogenic neuroplastogens, inspired by psychedelic research, to stimulate neuroplasticity for therapeutic benefits. Listen to Podcast…

In the shadow of headlines about the mental health crisis and the limits of current psychiatric care, one small biotech is making quiet but meaningful progress. Enveric Biosciences (NASDAQ: ENVB)…

New data confirms Enveric’s lead neuroplastogen acts on a serotonin receptor tied to depression, Parkinson’s, and migraine. Enveric Biosciences has announced that EB-003, its oral, non-hallucinogenic neuroplastogen, also acts as…

In an industry defined by bold ideas and even bolder challenges, Enveric Biosciences (NASDAQ: ENVB) is quietly making a case to lead the next generation of neuropsychiatric drug innovation. On…

With U.S. Patent No. 12,187,679 now granted, Enveric Biosciences has secured more than intellectual property—it’s staked a claim on the future of neurotherapeutics. The Cambridge-based biotech firm announced this week…

The psychedelic industry stands at the cusp of a transformative era, propelled by the development of next-generation molecules with the potential to be more effective treatments for a host of…

In a significant development for mental health treatments, Enveric Biosciences (NASDAQ: ENVB) has secured its first U.S. patent for a novel series of compounds that could transform how we approach neuropsychiatric disorders. The company’s…

Enveric Biosciences has secured its first U.S. patent for the EVM401 Series, a novel collection of non-hallucinogenic, mescaline-derived compounds. These compounds are designed to address addiction, ADHD anxiety, and other…